---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-105853"
form_type: "8-K"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:57:36.320902+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Armata Pharma VP Corporate Controller departs; receives base salary through Dec 2024

## Summary
- Richard Rychlik, VP Corporate Controller, employment ended September 30, 2024.
- Separation agreement provides continued base salary through December 31, 2024.
- Company also subsidizes COBRA premiums through December 31, 2024.
- No successor or replacement officer has been named.

## SEC filing metadata
- accession: 0001104659-24-105853
- form_type: 8-K
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465924105853/0001104659-24-105853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465924105853/tm2425499d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-105853
- JSON: https://secwatch.observer/filing/0001104659-24-105853.json
- Plain text: https://secwatch.observer/filing/0001104659-24-105853.txt

## Key facts
- Executive change
  Richard Rychlik departed as Vice President, Corporate Controller at Armata Pharmaceuticals, Inc..
  - Action: employment concluded
  - Role: Vice President, Corporate Controller
  source text: On September 26, 2024, Armata Pharmaceuticals, Inc. (the “ Company ”) disclosed that it had reached an agreement with Richard Rychlik, the Company’s Vice President, Corporate Controller, pursuant to which Mr. Rychlik’s employment would conclude effective as of September 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465924105853/0001104659-24-105853-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.